Deutsch English Français

Contact

EP2069521

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2069521

EP2069521 - BIOMARKERS OF MULTIPLE SCLEROSIS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 14.12.2012 Database last updated on 14.09.2024
Most recent event Tooltip	14.12.2012	Application deemed to be withdrawn	published on 16.01.2013 [2013/03]
Applicant(s)	For all designated states Biogen Idec MA Inc. 14 Cambridge Center Cambridge, MA 02142 / US
	[2009/41]
Former [2009/25]	For all designated states Biogen Idec MA, Inc. 14 Cambridge Center Cambridge, Massachusetts 02142 / US
Inventor(s)	01 / BURKLY, Linda C. 34 Winthrop Street West Newton Massachusetts 02465 / US
	02 / HAHM, Kyungmin 49 Eldred Street Lexington Massachusetts 02420 / US
	[2009/44]
Former [2009/25]	01 / BURKLY, Linda C. 34 Winthrop Street West Newton, Massachusetts 02465 / US
	02 / HAHM, Kyungmin 2360 Commonwealth Avenue 2-3 Aburndale, Massachusetts 02466 / US
Representative(s)	Adams, Harvey Vaughan John, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB
	[N/P]
Former [2009/25]	Adams, Harvey Vaughan John, et al Mathys & Squire LLP 120 Holborn London EC1N 2SQ / GB
Application number, filing date	07854043.2	15.10.2007
	[2009/25]
	WO2007US81374
Priority number, date	US20060851957P	16.10.2006 Original published format: US 851957 P
	[2009/25]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO2008048924
	Date:	24.04.2008
	Language:	EN
	[2008/17]
	Type:	A2 Application without search report
	No.:	EP2069521
	Date:	17.06.2009
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 24.04.2008 takes the place of the publication of the European patent application.
	[2009/25]
Search report(s)	International search report - published on:	US	03.07.2008
	(Supplementary) European search report - dispatched on:	EP	12.11.2009
Classification	IPC:	C12Q1/00, G01N33/53, G01N33/564	[2009/50]
	CPC:	C12Q1/6883 (EP,US); G01N33/948 (EP,US); C12Q2600/158 (EP,US); G01N2333/70575 (EP,US); G01N2800/285 (EP,US)
	Former IPC [2009/25]	C12Q1/00, G01N33/53
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR [2009/25]
Extension states	AL	31.03.2009
	BA	31.03.2009
	HR	31.03.2009
	MK	31.03.2009
	RS	31.03.2009
Title	German:	BIOMARKER FÜR MULTIPLE SKLEROSE	[2009/25]
	English:	BIOMARKERS OF MULTIPLE SCLEROSIS	[2009/25]
	French:	BIOMARQUEURS DE SCLÉROSE EN PLAQUE	[2009/33]
	Former [2009/25]	BIOMARQUEURS DE SCLEROSE EN PLAQUE
Entry into regional phase	31.03.2009	National basic fee paid
	31.03.2009	Search fee paid
	31.03.2009	Designation fee(s) paid
	31.03.2009	Examination fee paid
Examination procedure	31.03.2009	Examination requested [2009/25]
	25.06.2009	Amendment by applicant (claims and/or description)
	24.02.2010	Despatch of a communication from the examining division (Time limit: M06)
	27.08.2010	Reply to a communication from the examining division
	13.03.2012	Despatch of a communication from the examining division (Time limit: M04)
	24.07.2012	Application deemed to be withdrawn, date of legal effect [2013/03]
	29.08.2012	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2013/03]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.02.2010
Fees paid	Renewal fee
	26.10.2009	Renewal fee patent year 03
	25.10.2010	Renewal fee patent year 04
	25.10.2011	Renewal fee patent year 05
	Penalty fee
	Additional fee for renewal fee
	31.10.2012	06 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XA] - AGNELLO, D., ET AL, "Increased peripheral benzodiazepine binding sites and pentraxin 3 expression in the spinal cord during EAE: relation to inflammatory cytokines and modulation by dexamethasone and rolipram", JOURNAL OF NEUROIMMUNOLOGY, (2000), vol. 109, pages 105 - 111, XP002553063 [X] 4,6-10,15-17 * page 105 - page 108 * [A] 1-3,5,11-14,18-23 DOI: http://dx.doi.org/10.1016/S0165-5728(00)00279-4
		[XA] - IBRAHIM S M ET AL, "GENE EXPRESSION PROFILING OF THE NERVOUS SYSTEM IN MURINE EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS", BRAIN, OXFORD UNIVERSITY PRESS, OXFORD, GB, (20010101), vol. 124, no. 10, ISSN 0006-8950, pages 1927 - 1938, XP008020655 [X] 20,22 abstract, page 1928, table 1 [A] 1-19,21,23 DOI: http://dx.doi.org/10.1093/brain/124.10.1927
		[A] - YOSSI GILGUN-SHERKI ET AL, "Analysis of Gene Expression in MOG-Induced Experimental Autoimmune Encephalomyelitis After Treatment With a Novel Brain-Penetrating Antioxidant", JOURNAL OF MOLECULAR NEUROSCIENCE, BIRKHAEUSER, CAMBRIDGE, MA, US, (20050101), vol. 27, no. 1, ISSN 0895-8696, pages 125 - 136, XP007906193 [A] 1-23 abstract, page126, right-hand column, line 6 - page 128, right-hand column, line 22, figure 3 DOI: http://dx.doi.org/10.1385/JMN:27:01:125
		[A] - DESPLAT-JEGO S ET AL, "TWEAK is expressed by glial cells, induces astrocyte proliferation and increases EAE severity", JOURNAL OF NEUROIMMUNOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, XX, (20021201), vol. 133, no. 1-2, ISSN 0165-5728, pages 116 - 123, XP002323491 [A] 1-23 abstract, page 120, left-hand column, line 16 - page 121, left-hand column, line 2 DOI: http://dx.doi.org/10.1016/S0165-5728(02)00368-5
		[A] - DESPLAT-JEGO ET AL, "Anti-TWEAK monoclonal antibodies reduce immune cell infiltration in the central nervous system and severity of experimental autoimmune encephalomyelitis", CLINICAL IMMUNOLOGY, ACADEMIC PRESS, US, (20051001), vol. 117, no. 1, ISSN 1521-6616, pages 15 - 23, XP005046712 [A] 1-23 * the whole document * DOI: http://dx.doi.org/10.1016/j.clim.2005.06.005
		[A] - DEBRUYNE, J. C., ET AL, "PET visualization of microglia in multiple sclerosis patients using [11C]PK11195", EUROPEAN JOURNAL OF NEUROLOGY, (2003), vol. 10, pages 257 - 264, XP002553064 [A] 1-23 * the whole document * DOI: http://dx.doi.org/10.1046/j.1468-1331.2003.00571.x
	International search	[X]US2006211090 (BEJANIN STEPHANE [FR], et al);
		[Y]WO2006089095 (BIOGEN IDEC INC [US], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p